Edwin M. Kania Jr., 10% Owner at Eleven Biotherapeutics, Inc. (EBIO), sold 860,951 shares at $3.18 ($2.7M) on 2016-09-22, disclosed to the SEC on 2016-09-26.
Open-market sale of $2.7M EBIO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.17 | 47,090 | $149K | 5.5% |
| 2 | $3.17 | 47,090 | $149K | 5.5% |
| 3 | $3.17 | 188,367 | $597K | 21.9% |
| 4 | $3.17 | 188,367 | $597K | 21.9% |
| 5 | $3.18 | 28,163 | $90K | 3.3% |
| 6 | $3.18 | 28,163 |
| $90K |
| 3.3% |
| 7 | $3.18 | 112,731 | $358K | 13.2% |
| 8 | $3.18 | 112,731 | $358K | 13.2% |
| 9 | $3.10 | 10,293 | $32K | 1.2% |
| 10 | $3.10 | 41,178 | $128K | 4.7% |
| 11 | $3.10 | 41,178 | $128K | 4.7% |
| 12 | $3.16 | 3,118 | $10K | 0.4% |
| 13 | $3.16 | 12,482 | $39K | 1.4% |
| Total | $3.17 avg | 860,951 | $2.7M | 100% |
| Filing → |
| MRNA | SELL | 2019-12-11 | $3.8M | — | Filing → |
| TMDX | BUY | 2019-05-06 | $533K | — | Filing → |
| SELB | SELL | 2017-05-16 | $3.7M | — | Filing → |